US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

2.880
-0.030-1.03%

Close May 31 16:00 ET

2.910
+0.030+1.04%

Post 18:14 ET

262.19MMarket Cap-7024P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-217.79%-10.38M

35.02%-6.38M

-158.71%-4.94M

-183.59%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

130.99%2.81M

-273.69%-6.56M

Net income from continuing operations

-259.00%-12.83M

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

Operating gains losses

----

--1.03M

----

Depreciation and amortization

-36.31%207K

-43.65%1.35M

17.88%468K

-55.87%263K

-56.67%289K

-55.30%325K

-19.47%2.39M

-45.69%397K

-19.02%596K

-10.11%667K

Other non cash items

1,425.98%2.71M

-69.76%1.77M

3,492.59%1.83M

-96.05%88K

-97.25%52K

-111.49%-204K

-62.73%5.85M

-102.88%-54K

-53.74%2.23M

-56.35%1.89M

Change In working capital

-823.67%-2.05M

-116.70%-5.34M

-105.58%-1.1M

-111.99%-1.44M

-162.24%-3.09M

106.05%283K

1,948.38%31.98M

612.10%19.71M

709.25%11.98M

30.22%4.96M

-Change in receivables

106.63%147K

-141.80%-3.07M

-98.29%104K

-81.10%1.55M

-444.44%-2.51M

71.13%-2.22M

237.34%7.35M

343.92%6.1M

715.14%8.21M

136.12%729K

-Change in inventory

19.65%-965K

43.26%-989K

-67.16%310K

34.25%-1.13M

372.03%1.03M

-103.21%-1.2M

-10.53%-1.74M

180.34%944K

-7,054.17%-1.72M

-847.50%-379K

-Change in prepaid assets

-29.74%-253K

-7.79%1.29M

110.25%73K

-77.61%-595K

-25.00%2.01M

15.22%-195K

11.21%1.4M

-33.08%-712K

54.67%-335K

-12.75%2.68M

-Change in payables and accrued expense

39.78%-589K

-4,677.03%-3.54M

90.09%-114K

-81.01%479K

-225.19%-2.92M

74.13%-978K

-119.42%-74K

-134.84%-1.15M

362.81%2.52M

147.51%2.33M

-Change in other working capital

-107.96%-388K

-96.14%966K

-110.13%-1.47M

-152.71%-1.74M

-73.00%-692K

-35.89%4.87M

603.26%25.04M

7,515.31%14.53M

203.39%3.31M

-121.54%-400K

Cash from discontinued investing activities

Operating cash flow

-217.79%-10.38M

35.02%-6.38M

-158.72%-4.94M

-183.55%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

130.99%2.81M

-273.69%-6.56M

Investing cash flow

Cash flow from continuing investing activities

-1,350.00%-29K

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

-1,968.67%-1.72M

-248.97%-677K

Capital expenditure reported

-1,350.00%-29K

2.83%-995K

38.46%-16K

30.41%-151K

-22.01%-826K

98.08%-2K

-12.16%-1.02M

95.12%-26K

-161.45%-217K

-248.97%-677K

Net intangibles purchase and sale

----

--0

----

---1.5M

--0

----

Cash from discontinued investing activities

Investing cash flow

-1,350.00%-29K

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

-1,968.67%-1.72M

-248.97%-677K

Financing cash flow

Cash flow from continuing financing activities

988.01%81.74M

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

-102.27%-138K

17.41%10.2M

Net issuance payments of debt

99.94%-5K

-1,010.47%-22.49M

-390.81%-9.94M

51.41%1.02M

-564.30%-4.48M

---9.09M

---2.03M

--675K

---675K

Net common stock issuance

8,862.88%82.1M

-34.40%8.91M

-46.22%3.64M

-66.18%184K

-16.18%4.17M

-29.43%916K

-54.38%13.59M

30.38%6.76M

-91.06%544K

-42.19%4.98M

Proceeds from stock option exercised by employees

--539K

24,450.00%8.35M

99.56%-26K

120,100.00%4.8M

--3.57M

--0

-90.09%34K

-2,292.88%-5.86M

---4K

----

Net other financing activities

13.72%-893K

306,833.33%9.2M

658.52%10.24M

---1.03M

--1.02M

---1.04M

78.57%-3K

135,100.00%1.35M

----

Cash from discontinued financing activities

Financing cash flow

988.01%81.74M

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

-102.27%-138K

17.41%10.2M

Net cash flow

Beginning cash position

-12.47%23.87M

-2.68%27.27M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

-11.89%28.02M

-40.16%18.65M

-48.31%17.7M

-46.41%14.74M

Current changes in cash

18,342.46%71.33M

-352.86%-3.4M

-112.12%-1.05M

160.06%2.48M

-250.25%-4.45M

97.06%-391K

80.15%-751K

374.65%8.62M

131.07%954K

-56.07%2.96M

End cash Position

254.14%95.2M

-12.47%23.87M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

-40.16%18.65M

-48.31%17.7M

Free cash flow

-218.14%-10.41M

40.25%-7.38M

-159.09%-4.96M

-328.75%-2.5M

-20.64%-8.73M

160.43%8.81M

63.58%-12.34M

197.63%8.39M

111.94%1.09M

-271.23%-7.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-217.79%-10.38M	35.02%-6.38M	-158.71%-4.94M	-183.59%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M	130.99%2.81M	-273.69%-6.56M
Net income from continuing operations	-259.00%-12.83M	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M
Operating gains losses	----	--1.03M	----	----	----	----	----	----	----	----
Depreciation and amortization	-36.31%207K	-43.65%1.35M	17.88%468K	-55.87%263K	-56.67%289K	-55.30%325K	-19.47%2.39M	-45.69%397K	-19.02%596K	-10.11%667K
Other non cash items	1,425.98%2.71M	-69.76%1.77M	3,492.59%1.83M	-96.05%88K	-97.25%52K	-111.49%-204K	-62.73%5.85M	-102.88%-54K	-53.74%2.23M	-56.35%1.89M
Change In working capital	-823.67%-2.05M	-116.70%-5.34M	-105.58%-1.1M	-111.99%-1.44M	-162.24%-3.09M	106.05%283K	1,948.38%31.98M	612.10%19.71M	709.25%11.98M	30.22%4.96M
-Change in receivables	106.63%147K	-141.80%-3.07M	-98.29%104K	-81.10%1.55M	-444.44%-2.51M	71.13%-2.22M	237.34%7.35M	343.92%6.1M	715.14%8.21M	136.12%729K
-Change in inventory	19.65%-965K	43.26%-989K	-67.16%310K	34.25%-1.13M	372.03%1.03M	-103.21%-1.2M	-10.53%-1.74M	180.34%944K	-7,054.17%-1.72M	-847.50%-379K
-Change in prepaid assets	-29.74%-253K	-7.79%1.29M	110.25%73K	-77.61%-595K	-25.00%2.01M	15.22%-195K	11.21%1.4M	-33.08%-712K	54.67%-335K	-12.75%2.68M
-Change in payables and accrued expense	39.78%-589K	-4,677.03%-3.54M	90.09%-114K	-81.01%479K	-225.19%-2.92M	74.13%-978K	-119.42%-74K	-134.84%-1.15M	362.81%2.52M	147.51%2.33M
-Change in other working capital	-107.96%-388K	-96.14%966K	-110.13%-1.47M	-152.71%-1.74M	-73.00%-692K	-35.89%4.87M	603.26%25.04M	7,515.31%14.53M	203.39%3.31M	-121.54%-400K
Cash from discontinued investing activities
Operating cash flow	-217.79%-10.38M	35.02%-6.38M	-158.72%-4.94M	-183.55%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M	130.99%2.81M	-273.69%-6.56M
Investing cash flow
Cash flow from continuing investing activities	-1,350.00%-29K	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K	-1,968.67%-1.72M	-248.97%-677K
Capital expenditure reported	-1,350.00%-29K	2.83%-995K	38.46%-16K	30.41%-151K	-22.01%-826K	98.08%-2K	-12.16%-1.02M	95.12%-26K	-161.45%-217K	-248.97%-677K
Net intangibles purchase and sale	----	--0	--0	----	----	----	---1.5M	--0	----	----
Cash from discontinued investing activities
Investing cash flow	-1,350.00%-29K	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K	-1,968.67%-1.72M	-248.97%-677K
Financing cash flow
Cash flow from continuing financing activities	988.01%81.74M	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K	-102.27%-138K	17.41%10.2M
Net issuance payments of debt	99.94%-5K	-1,010.47%-22.49M	-390.81%-9.94M	51.41%1.02M	-564.30%-4.48M	---9.09M	---2.03M	---2.03M	--675K	---675K
Net common stock issuance	8,862.88%82.1M	-34.40%8.91M	-46.22%3.64M	-66.18%184K	-16.18%4.17M	-29.43%916K	-54.38%13.59M	30.38%6.76M	-91.06%544K	-42.19%4.98M
Proceeds from stock option exercised by employees	--539K	24,450.00%8.35M	99.56%-26K	120,100.00%4.8M	--3.57M	--0	-90.09%34K	-2,292.88%-5.86M	---4K	----
Net other financing activities	13.72%-893K	306,833.33%9.2M	658.52%10.24M	---1.03M	--1.02M	---1.04M	78.57%-3K	135,100.00%1.35M	----	----
Cash from discontinued financing activities
Financing cash flow	988.01%81.74M	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K	-102.27%-138K	17.41%10.2M
Net cash flow
Beginning cash position	-12.47%23.87M	-2.68%27.27M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-11.89%28.02M	-40.16%18.65M	-48.31%17.7M	-46.41%14.74M
Current changes in cash	18,342.46%71.33M	-352.86%-3.4M	-112.12%-1.05M	160.06%2.48M	-250.25%-4.45M	97.06%-391K	80.15%-751K	374.65%8.62M	131.07%954K	-56.07%2.96M
End cash Position	254.14%95.2M	-12.47%23.87M	-12.47%23.87M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-2.68%27.27M	-40.16%18.65M	-48.31%17.7M
Free cash flow	-218.14%-10.41M	40.25%-7.38M	-159.09%-4.96M	-328.75%-2.5M	-20.64%-8.73M	160.43%8.81M	63.58%-12.34M	197.63%8.39M	111.94%1.09M	-271.23%-7.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall